Hemostemix

Hemostemix is a clinical-stage biotech company focused on advancing ACP-01, our proprietary autologous (patient’s own) stem-cell therapy to help regenerate damaged tissue and restore blood flow. We share educational videos, webinars, & expert interviews on PAD/CLTI, angina, cardiomyopathies, vascular dementia, regenerative medicine, clinical-trial progress, & real-world data.

⚠️ Important Notice: ACP-01 is an investigational therapy and has not been approved by the U.S. FDA, Health Canada, or other regulators. Content on this channel is for informational purposes only and is not medical advice or promotion of any unapproved product. Always consult a qualified healthcare professional about your care.

📍 Florida Notice (SB 1768 – F.S. 499.0295): The physician may perform one or more stem cell therapies not yet approved by the U.S. FDA. You are encouraged to consult your primary care provider before undergoing any stem cell therapy.

© 2025 Hemostemix Inc. All rights reserved.